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Abstract. Rare disease clinician investigators are essential to ensure appropriate diagnosis, care, and treatment for the rapidly
growing rare disease population. As these researchers are spread across many specialties, learning the unique skill set for
rare disease research (RDR) can be a hurdle and may hinder progress in the field. The need for an RDR focused training
program for investigators in many specialties and backgrounds was identified in a needs assessment of trainees in the NIH
funded Rare Diseases Clinical Research Network. Based on this information, the Rare Disease Research Scholars Program
(RDRSP) was developed.
We describe the needs assessment, curriculum creation, scholar recruitment, and outcome evaluation based on four years
of programmatic data (2015–2019). This one year-long RDRSP uses a blended approach that includes in-person, webbased, synchronous and asynchronous learning. We evaluated the RDRSP using quantitative and qualitative approaches.
Quantitative measures included pre and post questionnaires about knowledge, self-efficacy, and intent to remain in RDR.
Data were analyzed using descriptive statistics and a paired t-test. Qualitative semi-structured interviews explored the RDR
scholars’ perceptions of the RDRSP; thematic analysis examined the textual data.
Quantitative pre- and post-measures were statistically significant in the following areas: 1) improved knowledge content
in RDR, 2) enhanced self-efficacy in clinical research, and 3) intent to remain in the field of RDR. Qualitative data analysis
found the program supported the development of the scholar’s research skills as well as ‘soft-skills’.
By combining training of skills unique to RDR with the more general topics of leadership, mentorship and collaboration
among participants in diverse specialties, we created a program that supports the development of the next generation of rare
disease clinician investigators and serves as a model for training in other niche research areas.
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Rare disease research (RDR) is a niche field that demands specific skills and interactions that are
not consistently fostered in the current academic research setting. Skills such as small population
statistics, collaboration among institutions, and interacting with family and patient organizations were
identified as unique skills. The field was propelled forward by the passing of the Orphan Drug Act
of 1983, PL 97-414. This landmark legislation denoted a rare disorder as affecting less than 200,000
persons in the U.S., and it has served to expand access to novel medications for hundreds of rare
disorders [1]. Using the terminology in this law, over 7,000 disorders are designated as “rare”; and
RDR spans multiple medical specialties and funding mechanisms. With the expansion of social media
and patient advocacy organizations such as the National Organization for Rare Disorders (NORD),
rare disease patients and their families are now able to rally behind their own rare disorder and work
towards faster diagnosis, improved treatment, and even cures in collaboration with health care providers
and researchers. With the ongoing increase in patient identification, there has been enhanced interest
in RDR from industry, the NIH and investigators. This is accompanied by the need to train clinician
investigators in performing clinical research studies in rare diseases. In 2009, Griggs et al. [2] reviewed
the opportunities, challenges, and proposed solutions to optimize production and retention of clinical
researchers in rare disease. In this seminal work, the need for niche field training was described and
led to the concept of rare disease training for individuals who already had specialty training. Since
that time, the demand for rare disease researchers has only expanded with the burgeoning of novel
diagnostics, biomarkers and treatments. This has led to the need to create new pathways of training in
rare diseases [3].
The NIH has provided significant support for RDR including the development of the Rare Disease
Clinical Research Network (RDCRN) to promote rare diseases clinical research, perform natural history studies, bring novel products to market and train scientist within the novel specialty field of RDR
(reviewed in Krischer [4]). The RDCRN is a network of 23 consortia (as of January 2020) focused
on 190 rare disorders [4]. Within each consortium and across consortia, best practices are shared to
move forward rare disease patient care and clinical research. While institutions in each consortium
have training programs in clinical research, we identified the need to create a cross-consortia, multidisciplinary RDR training program. Additionally, with the understanding that the need for training
was even greater outside of the consortia hubs, the program was designed to meet the needs of both
consortia-based and external early career rare disease researchers.
In 2015, the Rare Disease Scholars Program (RDRSP) was launched by the Children’s National Rare
Disease Institute, Children’s National Hospital, Washington, D.C., funded by an R25 curriculum grant
from NICHD and related to the institution’s Rare Diseases Clinical Research Center in Urea Cycle
Disorders. This year-long educational program incorporated survey data from early career rare disease
researchers, input from an invested oversight committee (the RDCRN Education Committee), and
involvement by medical educators with the knowledge base to create a multi-faceted blended training
curriculum.
The program development used the Lave and Wenger Communities of Practice theory of education,
whereby direct interaction with a community of experts and mentorship is the basis of a learning
experience [5]. This design employed two intensive day long in-person meetings and twice a month
web-based half-hour “touch points” throughout the year. Each web-based session met one of the
following criteria: 1) it provided a need identified in the assessment survey; 2) it involved an interaction
with a rare disease expert; and 3) it gave information that was immediately implementable to the
Scholar’s research. Additional optional content was created in a web-portal for lower need topics
identified on the survey.
In this paper we describe the development of this educational curriculum and the results of the mixed
methods of evaluation, incorporating immediate, long term, and qualitative feedback mechanisms.
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1. Methods
1.1. Needs Assessment
The RDCRN Education Committee performed an assessment of their trainees to identify specific
needs of the cohort prior to developing the curriculum and recruiting the Scholar Trainees from the
host institutions. A total of 159 trainees who had participated in the RDCRN training programs over
the preceding grant period were emailed an anonymous Survey Monkey link. There were no incentives
for completion of the survey. A total of 106 surveys (67%) were completed.
1.2. Creation of the Curriculum
The curriculum included an in-person day-long workshop at the beginning of the program, a capstone
meeting at the end of the program, bi-monthly webinars, and asynchronous learning opportunities
through a web portal. All webinars were recorded and uploaded onto LearnRD a Learning Management
System (LMS), along with other supporting documentation (i.e. PowerPoint slides, quizzes, handouts)
for those who needed to access them at differing times (http://childrensmedicaleducation.org/learnrd/).
Webinars included both general and RDR specific topics. Examples included: time management,
undiagnosed disease programs, grant writing, rare disease funding mechanisms, Curriculum Vitae and
Biosketch optimization, creation of educational portfolios, single subject study design, interactions
with industry, rare disease advocacy, creation of biorepositories, engaging in a natural history study,
and navigating regulatory affairs. Each year, several new topics were selected for presentation in
webinars or online modules based on a needs assessment obtained mid-year. In addition, each year
the full curriculum was re-assessed and re-designed based on the previous year’s cohort feedback and
end of year surveys. In addition, specific sessions on working with patient and family groups were
included based on studies showing the overall improvement in clinical research when these populations
are involved in trial design and oversight [6].
1.3. Creation of an Online Portal
In 2015, LearnRD.com was created by the authors to serve as an integral component of the RDRSP.
LearnRD.com is a LMS software that is used to deliver education courses, training programs, and
development activities by administering quizzes/exams, course surveys, confidence level tests, and
more while serving as a resource hub for teachings and learning materials. The LearnRD.com uses
Moodle software, a course management software that runs on an open-source learning platform. The
site is designed with username/password protection that allows for recordings of webinar session to
be posted and stored. Alumni are welcome to return to review content or watch new content.
1.4. Scholar Recruitment
Scholars were recruited using multiple modalities. Initially, recruitment was through the RDCRN
Education Committee and their junior faculty connections. As a result, in the first year, 91% of participants were affiliated with the RDCRN. Over time advertising at Rare Disease meetings, word of
mouth, and encouraging non-traditional applicants (i.e. research genetic counselors, pharmacists) led
to the participant levels from RDCRN-affiliation decreasing to about 70% in years three and four of
the program. Aggressive external advertising for year five led to more than half of enrollees having no
affiliation with the RDCRN. A total of 20 Scholars were accepted in year 1 with a maximum of 32 in
year 3.
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For individuals not chosen for a cohort, the most common reason was the level of training (too early or
too experienced). Scholars were accepted during their final year of fellowship training and up to 5 years
after beginning a faculty position. For PhD lab-based trainees, pharmacists, and genetic counselors,
the terminal degree must have been completed and a letter of recommendation provided indicating
a unique RDR interest and/or experience. Through the R25 funding up to 20 Scholars were offered
partial reimbursement to off-set travel costs. All applications underwent a standard review process
and top scored applicants were offered travel cost support. In years where additional applicants were
identified and were able to support their own travel costs, additional Scholars where included in the
program. Thus, the class size was based on funding and access to travel expense cost funding.
1.5. Outcome evaluation
By enrolling each scholar in the online learning portal (LearnRD.com) and in ORCID, data collection
throughout the course and in follow-up was possible. Scholars were asked to complete the following:
1) pre/post subject content test, 2) an inventory of topics deemed important for RDR success, 3) the
CRAI-12 clinical research self-efficacy evaluation, and 4) a questionnaire asking their likelihood of
being involved in RDR in 10 years. All the scores were normalized to a maximum value of 10 points,
and a paired T-test analysis was performed to determine significance.
The subject content test involves 34 multiple choice questions related to the field of rare disease research. Topics that were included and the questions were reviewed by the RDCRN Education
Committee.
A second assessment is 12 questions that measure their level of comfort with their skills in performing
RDR. These questions were created by the first author and evaluated and edited by the RDCRN
Education Committee prior to implementation. Each question offers the participant a 10-point Likert
scale with 0 = no expertise to 10 = expert. These questions were used to assess the Scholars knowledge
of RDR-specific topics, such as small cohort statistics and forming collaborations researchers at other
centers.
The Clinical Research Appraisal Inventory (CRAI-12) was developed by the University of Wisconsin
to “assess an individual’s perceived abilities to perform tasks and activities needed to conduct clinical
research”[7]. The CRAI assesses several aspects of clinical research by prompting takers to indicate
their ability to successfully perform a task by selecting a single number from 0 to 10 that best describes
their level of confidence. The assessment is broken up into sections: (1) conceptualizing a study, (2)
designing a study, (3) collaborating with others, (4) funding a study, (5) planning and managing a
research study, (6) protecting research subjects and responsible conduct of research, (7) collecting,
recording and analyzing data, (8) interpreting data, (9) reporting a study, and (10) presenting the
study. The scholar’s self-efficacy with clinical research is rated by indicating confidence level (0 = No
Confidence to 10 = Total Confidence) [7]. Self-efficacy is considered an important factor in making
career decisions and in outcomes of the decision [8, 9]. Because self-efficacy can change over a period
of time, the RDRSP administers the CRAI-12 of all scholars’ pre and post the program to identify the
impact of the program in trainees’ confidence in their abilities.
1.6. Qualitative evaluation interviews and analysis
To further evaluate the long-term outcomes of the program, all former Scholars were offered the
opportunity to be interviewed [10, 11]. The interview was conducted by an individual (author JW)
who was not involved in the curriculum creation or implementation. The purpose of the interview
was to understand the participant’s experiences in the program. A semi-structured interview guide
was developed to identify content of the program that was perceived to be beneficial (or not) for their
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long-term career development in RDR skills. The RDRSP Alumni council reviewed the questions
prior to the interviews. Interviews were conducted over the telephone and were designed to be thirty
minutes. Detailed memos were written after each interview [10]. The interviews were summarized and
de-identified, and only de-identified summaries and thematic information were provided to the full
research team. Thematic analysis was conducted iteratively using NVivo11 Plus, and data collection
continued until saturation was reached [12, 13].
1.7. Statistics
Each Scholar’s performance was compared before and after course completion. Paired T-test was
performed using Excel to determine significance. Participants who did not complete both the pre and
post evaluation were removed from the study, as was prescribed by the IRB (allowing individuals to
remove their data from the data set by not completing the final evaluation). We recognize that this may
have led to a skewed data set (i.e. lower scoring pre-evaluation participants not completing the final
evaluation).
1.8. Ethics statement
The Children’s National Hospital Institutional Review Board determined that the evaluation of this
educational program was a Research Quality Improvement Study and, as such, was exempt from IRB
review. Scholars were free to stop participation in the program at any time. While completion of the
post-test was required for graduation from the program, participants were offered to have their results
removed from the overall data set if they preferred. All data is presented as averaged values to prevent
identification of any individual’s scores.
2. Results
2.1. Needs Assessment
The RDCRN Education Committee performed an initial Needs Assessment from among 106 trainees
in 100 host institutions. Sixty-eight percent of trainees (72 of 106) replied to the survey and were either
fellows or junior faculty members from 22 medical specialties who intended to remain in academic
medicine. Others did not intend to stay in academic medicine or had a non-MD degree. The type of
RDR they were pursuing was fairly equally divided between clinical (58.5%) and basic/translational
(41.5%). Twenty-six groups of rare diseases were represented, overlapping largely with the respective
RDCRN consortium with which they were affiliated. Thirty-eight percent of trainees were engaged
in NIH funded mentored career development awards (K awards). Specific RDR training at their host
institution covered 1-2 years for 68% of trainees, with the remainder being involved in longer duration
training programs. Thirty-two percent of trainees collaborated with institutions outside of their host
institution. Eighty-three percent of trainees presented their research at national meetings; and 97%
published their work in a peer reviewed journal. There was also a strong relationship with the NIH
funded CTSA training programs at the trainee’s host institution. Mentorship was a strong part of
the trainees’ experience, with over 96% indicating they had a mentor for their RDR project. Almost
80% reported that they have had sufficient time to accomplish their research goals, with most having
50–75% funded protected time. Forty percent had attended one of the RDCRN’s R13-supported training
conferences. Almost 70% of trainees indicated that they plan to remain in the field of rare diseases,
and over three-quarters planned to remain in academic medicine. These individuals also indicated that
they planned on submitting an R or K award application in the 2 years following the survey.
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Table 1
Description of educational content for the Rare Disease Scholars Program as it iteratively expanded based on feedback from
scholars
Specific Sub-topics Identified
Clinical
Research
Skills

Laboratory
& Research
Management

RDR Biostatistics
Grant Writing with small cohort
Understanding genomics
Development interdisciplinary teams
Manuscript writing
Networking with others in RDR
Exposure to RDR outside sub-specialty
or home institution
Budgeting in RDR
Working with patient advocacy groups
Patient recruitment
Personal mentoring
Personal accountability
Time management
Human Resources (hiring, firing)

Needs
Assessment

Incorporated
Year 1

x
x
x
x
x
x
x

x
x
x
x
x
x
x

x
x

x
x
x
x

Incorporated Year 2–4
Expanded

Expanded: team projects
Expanded: travel and team
science projects

x
Expanded
x
x

We concluded that those individuals engaged in a RDCRN-based training program were receiving
adequate clinical research support and mentorship. When asked what additional training was needed,
there was strong support for a centralized training curriculum in RDR included multiple areas of content
specific for RDR (Listed in Table 1). The top needs identified were in the areas of clinical research skills
(i.e. biostatistics, grant/manuscript writing, genomics, creation of teams, networking), Laboratory and
Research Management (i.e. budgets, working with advocacy groups, patient recruitment, personal
mentoring, human resource training). This needs assessment provided us with a context for developing
the R25 RDR curriculum application. While the surveyed individuals were all housed in RDCRN based
programs, their needs became the basis for the RDRSP which was expanded to individuals without
access to a RDCRN training program and its resources.
2.2. Scholars Outcomes
Recruitment of Scholars to the program relied on the Education Committee identification of RDCRN
participants, word of mouth, and presentations at rare disease-centric meetings (National Organization
for Rare Disorders, RDCRN Rare Disease meeting, American College of Medical Genetics, and
Society of Inherited Metabolic Disorders). Four cohorts were included in the data set (Fig. 1). The
most common specialty noted by participants was neurology, followed by genetics and nephrology. The
“other” category included the lab-based (PhD most often) participants without a clear sub-specialty
association, pharmacists, urologists, general surgeons and other specialties for which there were fewer
than 3 participants in the program. Most participants held an MD/DO degree. Sixty-three percent of
participants were female, and 89% were affiliated with a laboratory in the U.S.; Canada was the highest
international participant.
Participants completed pre and post evaluations of an inventory of topics deemed important for
RDR success, the CRAI-12 evaluation, and were asked their likelihood of being involved in RDR in
10 years. These pre vs. post evaluations showed a significant effect of the program based on paired
T-test analysis (Fig. 2). Subject content knowledge showed an averaged increase each year; combined
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Fig. 1. Top Pie Chart: Degrees of the Scholars admitted to the program (n = 130). Bottom Pie Chart: Specialties of the Scholars
(n = 130). Other was used for any specialty field with one or fewer participants.

Fig. 2. Scholar outcomes pre and post the year-long R25 program. Participants completed pre and post evaluations of an
inventory of topics deemed important for rare disease research success, the CRAI-12 evaluation, and asked their likelihood of
being involved in Rare Disease research in 10 years. All were significantly increased based on paired T-test analysis (T-test
value p < 0.001). Only participants that completed both the pre and post-test were included in the statistical analysis. Including
individuals that completed only one of the tests (pre or post) did not change the overall trend or statistical significance of the
data set (n = 47–61, T-test p < 0.01).

data from four years is presented in Fig. 2. Each item on the CRAI-12 ranges from 0 to 10, with a
higher score indicating more confidence. Scores were normalized to a 10 point scale for graphical
representation. Pretest score increased from 6.83/10 to 8.07/10 (Normalized to a 10 point scale, each
question p < 0.001). Comfort with RDR methodology increased from 6/10 to 7.5/10 (p < 0.001). CRAI12 scores increased by 30% (p < 0.001) with clinical research self-efficacy increasing from an initial
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mean score of 6.0/10 to 7.9/10 (p < 0.001). Likelihood of remaining in RDR for 10 or more years
increased from 6.3/10 to 8.4/10 (p < 0.001).
2.3. Qualitative feedback evaluation
While the volunteer nature of providing qualitative feedback likely skewed our analysis to more positive results, the identification of themes that are important to reinforce and prioritize in future training
programs was deemed important by the oversight team. The data supported the generation of a theme
where “participants acknowledged importance of research skills and knowledge but also highly-valued
the program for the development of their ‘soft-skills’ in research.” Primary categories supporting this
theme were collaboration (n = 8), mentorship (n = 8), research skills (n = 9), and personal development (n = 9) (Table 2). Each category had multiple sub-categories identified that led to suggestions
for interventions needed to promote success of the program. The combination of needing resources,
support, and community-building was seen across multiple categories. We believe that this theme is
applicable to all types of training programs working with early career individuals in the biomedical
sciences.
3. Discussion
RDR is in a sense a new discipline. Representing over 7,000 diseases, it crosses specialty boundaries
in medicine and requires team science. The NIH recognized this with the establishment of the RDCRN
in 2003. Yet, fellowship and career development training programs tend to be subspecialty or disease
specific. So, while trainees and early career faculty have developed a knowledge base in their specialty,
if they intend to pursue RDR they need an additional set of skills. This was identified by the needs
assessment described in this paper.
In response to this identified need we developed the RDRSP. This one-year curriculum uses a blended
learning approach that included in person meetings, webinars and a LMS. While we initially focused
on teaching skills specific to RDR, such as single subject design, recruitment in vulnerable populations
etc., we found that equally important were more general topics of how to prepare oneself for a successful
academic career. This finding of the importance of combining specific skills with general skills training
is likely applicable to all training programs. We also found that developing a community of scholars
who were diverse but focused on a specific topic, RDR, yielded a cohesive cohort of learners. The total
investment of time, less than 6 weeks of training over the year curriculum, was able to be managed by
even the busiest specialty scholar. The effectiveness of the program was demonstrated by a significant
increase in tested knowledge and self-efficacy, as well as a positive quantitative assessment of the
course value.
Furthermore, by creating an agile curriculum with space for year-specific content, each cohort’s
unique needs were addressed. For example, in 2020 when COVID-19 became a hurdle for early career
researchers, sessions were executed to strategically support researchers working from home. Quickly,
the need for psychosocial support led to several sessions with a “happy hour” theme that offered a
community and caring for scholars from the front lines of New York City COVID wards, to those with
young children sequestered at home, and those without local family struggling with loneliness. Thus,
the agility of the curriculum to meet current needs created a program that could remain timely even
during the 2020 pandemic or the next hurdle that will present itself to rare disease clinical researchers.
The unique approach to this program allowed for creation of a community of diverse rare disease
researchers, leading to increased collaboration, support, and skills for the Scholars. We believe that
basic career development skills and creating a network of like-minded individuals are essential to

Table 2
Qualitative feedback identified a theme supporting the need to develop soft-skills in rare disease research. Scholars were interviewed using a semi-structured template to
explore areas of improvement and benefits of the Scholars Program. All Scholars from the 4 years were offered an interview. Interviews were conducted across all cohorts
equally and continued until thematic saturation was accomplished
Theme: “Participants acknowledged importance of research skills and knowledge but also highly-valued the program for the development of their
‘soft-skills’ in research.”
Category
Collaboration
(n = 8)

Description
Increased opportunities to network and
breakdown silos

Sub-Category
Networking within program

Staying Connected

Mentorship (n = 8)

Opportunities to find mentors and advisors to
receive guidance from experts

Learning from those more
senior
Outsider perspective from
program leader

Research Skills
(n = 9)

Opportunities to learn the nuts and bolts of
research

Funding & Grants

Reading & Writing
More content

Personal
Development
(n = 9)

Opportunities to learn how to balance
multiple roles, time, and advance one’s
career.

Career Advancement

Time Management

Describing your research

D.S. Regier et al. / The Rare Disease Research Scholars Program

Engaging with the research
system

Examples of feedback from Scholars
-I met a lot of people that can relate to working with rare diseases.
-I have about three or four people I can get advice from. Just knowing that there are people.
-Gaining visibility is the best part about the program. I went to NIH, spoke with program officers, and gave
presentations.
-I presented at the RDCN steering committee
-I’d love to continue meeting with [program leader] monthly and staying in touch with the scholars.
-We had one face to face and that was good . . . seeing them face to face helps you make connections beyond
the online portal. You saw where they were coming from and you could make collaborations and even
friends. It would be nice to do this twice.
-If there was somebody who could keep the group continuously conversing that would be helpful.
-It was good to learn from someone 5–10 years ahead of me. Life advice in research—it is so different from
medical school.
-Seeing her [program leader] leadership and professionalism was great for me. I know I have a good
professional role model.
-I have mentors at my home institution but to have an outside perspective. It was good to hear different
institutional support.
-The resources—being able to use them when you’re writing grants.
- . . . tapping into unusual places like the Department of Defense
-There were talks about searching for funding and knowing where to look.
-I learned how to read articles more critically
-Helped me to write an IRB while thinking about what I wanted to do now and in the future.
-As a clinician, I felt like I needed a 1:1 grant session
-We need to know more about contracts, what makes it good or bad.
-I would add more statistics, analysis . . . knowing how to get the best information from a small sample size.
-The program benefitted me [at work] because it elevated my career as I’m now the site leader. The program
fueled my passion to engage more and find collaborations.
-After the program, I was able to secure a new position as a post-doctoral researcher.
-I was one of three abstracts selected for an oral presentation and this was a boost.
-I learned how to optimize my small amount of time to research
-For time management there was a lot of opportunities to dig into so additional resources for other topics and
easily digestible options like the short ted talks.
-It was good to hear tips but also that others are struggling.
- . . . no one learns this in books. I learned how to give an elevator pitch about my ideas.
-It [guest lecture] inspired me to when I give results especially with complicated things to custom create a
handout.

9
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effectively equip and encourage early career researchers. Both the early surveys and the follow-up
qualitative interviews identified the mentorship theme. While this is certainly not a novel concept in
education [14], the importance of various types of mentorship and developing a broad mentorship team
came to light. With progression of the program over time, additional training and mentorship in nonresearch-based topics was identified as a priority. From issues such as human resource management
and time management to life/work balance, the topics most appreciated were often not scholarly, but
more the soft skills of interpersonal relationships. Time spent on discussing these skills should be
prioritized to ensure that these needs are being met.
In our ongoing work to keep the value of the program high to participants, we have attempted to
decrease the amount of any “busy work” for participants. While other programs have pre-reading and
post activities, which have been shown to increase retention of topics, we instead used the approach to
familiarize the participants to the resources and then make them readily available when needed (adult
learning theory). Thus, all topics are recorded and stored on LearnRD.com for participants to return
to use. The portal access is allowed indefinitely after completion of the course and alumni Scholars
are welcome to join future conversations or topics as they need additional resources or support. This
approach has increased the interaction with the material without increasing the initial time commitment,
which can lead to learner fatigue. The only “scut” work is the pre and post tests and creation of a poster
for the final presentations. Due to the concerns that some did not want to create an additional poster,
we now accept poster presentation from other meetings and review their posters remotely.
An alumni network was created in 2018 to connect scholars of different years with each other. This
group now works with the primary team on recruitment, Scholar selection, and activity oversight. We
continually collect updated CVs of former scholars to share and we also use ORCID IDs to keep
track of new publications by our scholars. Future data collection will focus on participant publications,
funding, and faculty positions as outcomes of the cohort. By monitoring long term implications of this
program, we will best direct future training programs for clinical researchers. The goal is to optimize
the training program to give maximal resource and skills with the minimal time and cost for busy early
career individuals.
Outcomes of the blended learning RDRSP curriculum showed improved readiness for clinical
research. Participant’s feedback shows increased expectation of staying in RDR, increased understanding of important concepts in rare disease research, and increased comfort with clinical research
topics. We believe that a blended learning curriculum based on both subject specific and general career
development topics may be applicable to other niche specialties in medicine.
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